UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.07 +0.07 (+0.09%) GOLD FUTURES
2,315.10 +4.10 (+0.18%) DOW
38,216.76 +313.47 (+0.83%) Bitcoin GBP
47,207.67 +947.80 (+2.05%)
Ovid Therapeutics Inc. (1OT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:12AM CEST. Market open.
| Previous close | 2.8600 |
| Open | 3.0800 |
| Bid | 2.8400 x 0 |
| Ask | 2.9000 x 0 |
| Day's range | 3.0800 - 3.0800 |
| 52-week range | 2.4600 - 3.6800 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 199.686M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ovid Therapeutics (OVID) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.